Shareholders have already approved a pay increase for British American Tobacco chief executive Tadeu Marroco. He could ...

In a report released on April 11, Salveen Richter from Goldman Sachs maintained a Buy rating on Regeneron (REGN – Research Report), with a ...

The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of reciprocal tariffs later this week.

GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk adults aged 50-59 this week. Read more here.

Goldman Sachs said Monday that GSK (NYSE ... in our view.” While Moderna (MRNA) has an FDA-approved RSV vaccine, its messenger-RNA-based shot is only approved by the FDA for those aged 60 ...

The Goldman Sachs Equal Weight U.S. Large Cap Equity ... Looking at individual holdings, Moderna Inc (MRNA) accounts for about 0.22% of total assets, followed by Entegris Inc (ENTG) and Dollar ...

In this article, we are going to look at where Moderna, Inc. (NASDAQ ... and a supportive regulatory environment, Goldman Sachs referred to it as an “undervalued opportunity.” ...

To come up with the list of stocks protected from tariffs and interest rates, we looked at the recently released list of Goldman Sachs’ top stocks with micro-driven volatility. Moderna ...

The major U.S. equity indexes were lower midday Monday, as the Trump administration showed no signs of pulling back from ...